CompletedNCT01314001
Nicotine Metabolism and Response to Smoking-Cessation Treatments
About this title
Read the official source — NCT01314001Medication studyAges 18–65United States + CanadaAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Buffalo and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateDecember 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 1,246
- Sponsor
- University of Pennsylvania
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01314001
- Official title
Show the full official title
Pharmacogenetics of Nicotine Addiction Treatment (PNAT)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Buffalo, United States · Philadelphia, United States · Houston, United States
1 more locations
- Toronto, Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Pennsylvania, a university.
Did this study involve medication?
Yes. The study involved medication, including Varenicline, Placebo and Transdermal Nicotine.
Who was this study for?
Listed age limits: 18 years to 65 years.
